Skip to main content
Table of Contents
Print

Are There Age Restrictions for Medical Cannabis Use in CRPS Patients? 

Author: Dr. Clarissa Morton, PharmD

When it comes to CRPS related medical cannabis access, age can be a deciding factor, especially for younger patients. While there is no universal minimum age, access to cannabis for pain conditions like CRPS is strictly regulated, and prescriptions for children or adolescents are considered only in exceptional cases. 

For adults, the process is more straightforward: if you have a confirmed diagnosis and have not responded to standard therapies, you may qualify for cannabis treatment. But for patients under 18, doctors must weigh potential therapeutic effects against developmental risks and a more cautious legal framework. 

How Age Affects Access 

Here’s how age influences CRPS related medical cannabis access and clinical decisions: 

  • Adults (18+) 
    Most prescriptions are granted to adult patients, where the benefits, such as reduced pain levels, improved sleep, and better emotional well-being, are weighed against known risks in a regulated clinical setting. 
  • Minors (under 18) 
    Prescribing is rare and only considered if the CRPS is severe, unresponsive to other treatments, and causing a significant reduction in quality of life. 
    Specialist teams assess both physical and psychological impacts before approval. 
  • Pain tolerance and perception 
    Age can affect pain threshold and the emotional response to chronic conditions. Cannabis may help manage both but must be tailored carefully with professional oversight. 

While cannabis can offer hope for CRPS patients, medical cannabis access for CRPS remains age-sensitive, especially in younger populations where long-term safety data is still developing. 

Visit providers like LeafEase for age-appropriate guidance and comprehensive cannabis consultations. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories